本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

65.75
+0.40000.61%
盘后:65.750.00000.00%19:30 EDT
成交量:177.89万
成交额:1.17亿
市值:128.74亿
市盈率:-18.42
高:66.42
开:65.35
低:65.20
收:65.35
52周最高:93.42
52周最低:52.75
股本:1.96亿
流通股本:1.67亿
量比:0.68
换手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-26.00%
市净率:-5.12
市盈率(LYR):-17.37

数据加载中...

2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/16

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities